Murphy & Mullick Capital Management Corp Invests $975,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Murphy & Mullick Capital Management Corp acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent filing with the SEC. The fund acquired 1,868 shares of the medical equipment provider’s stock, valued at approximately $975,000. Intuitive Surgical accounts for approximately 0.9% of Murphy & Mullick Capital Management Corp’s investment portfolio, making the stock its 25th biggest holding.

Several other large investors have also added to or reduced their stakes in ISRG. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $31,000. Finally, Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $36,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $519.81 on Wednesday. The company has a market cap of $185.15 billion, a P/E ratio of 81.09, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a 50-day simple moving average of $561.24 and a two-hundred day simple moving average of $532.59.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ISRG. Raymond James upped their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Stifel Nicolaus increased their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Jefferies Financial Group increased their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Finally, Barclays boosted their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $611.86.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at $2,793,033.06. The trade was a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last quarter. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.